Research. Education. Action.
We are the leading scientific membership organization advancing the science-based understanding of the causes, consequences, prevention and treatment of obesity in order to improve the lives of those affected.
Upcoming 2018 TOS submission deadlines.
Grants Program Letters of Intent:
May 22, 2018
Awards Nominations:
June 4, 2018
TOS Abstract Submission for ObesityWeek 2018
Submit Late-Breaking Abstracts July 20 – August 6.
Find Abstract Information
Research. Education. Action.
We are the leading scientific membership organization advancing the science-based understanding of the causes, consequences, prevention and treatment of obesity in order to improve the lives of those affected.
Upcoming 2018
TOS submission deadlines.
Grants Program Letters
of Intent:
May 22, 2018
Awards Nominations:
June 4, 2018
TOS Abstract Submission for ObesityWeek 2018
Submit Late-Breaking Abstracts July 20 – August 6.
Find Abstract Information
Advancing the Science of Obesity
You can make a difference.
Getting Connected
Learn moreGetting Connected
The Obesity Society connects with experts, government/non-government organizations and the public to:
- Develop, influence and promote vital policies and public positions
- Create and implement guidelines and cross-discipline learning, sharing and action that advances healthy behaviors
- Reduce obesity-related bias
Supporting Interactions
Learn moreSupporting Interactions
The Obesity Society works with professionals and various audiences on:
- Valuable conferences and educational opportunities, including early-career professional development and achievement programs
- Informative professional/academic and popular publications
- Essential financial development and support
Increasing Impact
Learn moreIncreasing Impact
The Obesity Society also helps leaders, investigators and innovators to:- Launch and promote needed public health initiatives
- Translate basic science and clinical trial results into real-world interventions
- Expand the boundaries of scientific exploration
News You Can Use
Study shows impact of exogenous ketones
A study performed by Brianna J. Stubbs and colleagues suggests that exogenous ketones, independent of diet…
Can fasting “flip the metabolic switch”?
Stephen D. Anton, PhD, and co-authors discuss why intermittent fasting may be beneficial for weight loss, metabolic syndrome, lipid profiles and…
Differing impacts of resistant starch
In a recent study, obesity prone (OP) and obesity resistant (OR) rats were fed a low-fat diet, with and without resistant starch. The OP group…
The role of exercise in avoiding high-calorie foods
Researchers at the University of Southern California found that greater “chronic” physical activity (as opposed to structured exercise) was…
THE OBESITY JOURNAL
Providing you groundbreaking scientific information and research in each issue.
GRANTS & AWARDS
Recognizing leading-edge explorations and achievements in the obesity field.
RESOURCES
Helping you find facts, clinicians, connections, careers and vital information.
NEWSROOM
Supplying the latest news about the entire obesity field.
ABSTRACTS DELIVERED
AT OUR ANNUAL MEETING
SUBMISSIONS & CITATIONS
TO THE OBESITY JOURNAL
AMOUNT WE GRANTED & AWARDED
TO PROFESSIONALS IN THE OBESITY FIELD
OTHER ORGANIZATIONS
ACTIVELY PARTNER WITH US
PROFESSIONALS ATTEND
OBESITY SOCIETY EVENTS
Continuing a Heritage of Leadership
TOS President
Caroline Apovian, MD, FACP, FTOS, DABOM
Dr. Caroline Apovian, a nationally and internationally recognized authority on nutrition and obesity medicine, is professor of medicine and pediatrics in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine.
Dr. Apovian also serves as director of the Center for Nutrition and Weight Management at Boston Medical Center. She has authored more than 10 books and more than 170 peer-reviewed original research and review articles on obesity and nutrition.
Her research includes: the study of weight loss/gain and its effects on adipose tissue metabolism and inflammation; obesity and cardiovascular disease; diabetes and cardiovascular disease in the bariatric surgery population; disparities in the treatment of obesity in underserved populations; and investigations into novel pharmacotherapeutic agents for the treatment of obesity.
TOS President Elect
Steven B. Heymsfield, MD, FTOS
Dr. Steven B. Heymsfield, is a widely published author, educator and researcher who has extensively investigated topics ranging from obesity and malnutrition to cachexia, body composition and caloric expenditure.
He currently serves as professor and director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center of the Louisiana State University System in Baton Rouge.
His previous positions include professor of medicine and deputy director of the New York Obesity Research Center at Columbia University. Dr. Heymsfield has published more than 600 peer-reviewed papers and has received numerous awards for his studies in the field of human nutrition.
TOS President Elect
Steven B. Heymsfield, MD, FTOS
Dr. Steven B. Heymsfield, is a widely published author, educator and researcher who has extensively investigated topics ranging from obesity and malnutrition to cachexia, body composition and caloric expenditure.
He currently serves as professor and director of the Body Composition-Metabolism Laboratory at the Pennington Biomedical Research Center of the Louisiana State University System in Baton Rouge.
His previous positions include professor of medicine and deputy director of the New York Obesity Research Center at Columbia University. Dr. Heymsfield has published more than 600 peer-reviewed papers and has received numerous awards for his studies in the field of human nutrition.
TOS Vice President
Lee M. Kaplan, MD, PhD, FTOS
Dr. Lee M. Kaplan is director of the Obesity, Metabolism and Nutrition Institute at Massachusetts General Hospital (MGH) and founding director of the hospital’s Weight Center. He is also associate professor of medicine at Harvard Medical School (HMS). Dr. Kaplan’s research focuses on the role of the gastrointestinal tract in the regulation of energy balance and metabolic function, including the mechanism of action of bariatric and metabolic surgery. He has authored more than 200 medical and scientific papers.
Dr. Kaplan is director of the subspecialty fellowship program in Obesity Medicine and Nutrition at MGH; director of the Blackburn Course in Obesity Medicine at HMS; and associate director of the Nutrition and Obesity Research Center at Harvard, which is sponsored by the National Institutes of Health. He is a diplomate of the American Board of Obesity Medicine and a diplomate in internal medicine and gastroenterology of the American Board of Internal Medicine.
TOS Immediate Past-President
Allen Levine, PhD, FTOS
Dr. Allen Levine serves the University of Minnesota as vice president for research; professor in the Department of Food Science and Nutrition; and adjunct professor in the Department of Psychiatry. He has also served as director of the Minnesota Obesity Center for many years.
Dr. Levine has spent more than four decades researching the neural regulation of food intake. He has published more than 300 scientific papers and over 100 review articles, editorials, and book reviews. Dr. Levine and his colleagues have published extensively on the influence of opioids, neuropeptide Y, melanocortins, and oxytocin on ingestive behavior, particularly related to the rewarding properties of food.
TOS Immediate Past-President
Allen Levine, PhD, FTOS
Dr. Allen Levine serves the University of Minnesota as vice president for research; professor in the Department of Food Science and Nutrition; and adjunct professor in the Department of Psychiatry. He has also served as director of the Minnesota Obesity Center for many years.
Dr. Levine has spent more than four decades researching the neural regulation of food intake. He has published more than 300 scientific papers and over 100 review articles, editorials, and book reviews. Dr. Levine and his colleagues have published extensively on the influence of opioids, neuropeptide Y, melanocortins, and oxytocin on ingestive behavior, particularly related to the rewarding properties of food.
TOS Secretary/Treasurer
Dale Schoeller, PhD, FTOS
Dr. Dale Schoeller is professor emeritus in the Department of Nutritional Sciences at the University of Wisconsin. His work in human energy metabolism contributed to a revised understanding of human energy requirements based on expenditure.
He also helped refine the study of the development of obesity and of weight loss treatment. Dr. Schoeller performed a post-doctoral fellowship at the Argonne National Laboratory. He has served as associate director of the Clinical Nutrition Research Unit at the University of Chicago and holds degrees from the University of Wisconsin-Milwaukee and Indiana University.